PubRank

Paolo Foa

Author PubWeight™ 23.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. Lancet Oncol 2013 4.55
2 Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol 2010 2.89
3 Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 2007 2.42
4 Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005 2.11
5 Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. J Natl Cancer Inst 2008 1.92
6 Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol 2011 1.47
7 A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma. Oncologist 2013 0.97
8 Fatigue and functional dependence in older cancer patients. Am J Clin Oncol 2008 0.95
9 Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population. BMC Cancer 2012 0.94
10 miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo. Clin Sci (Lond) 2014 0.84
11 Biomolecular markers in cancer of the tongue. J Oncol 2009 0.82
12 Rhodococcus equi infection in a patient with spinocellular carcinoma of unknown origin. J Med Microbiol 2008 0.82
13 Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicity. Anticancer Drugs 2006 0.81
14 A review on the treatment of relapsed/metastatic head and neck cancer. Expert Opin Pharmacother 2009 0.78
15 A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer. Anticancer Drugs 2009 0.78
16 Multimodality treatment of osteosarcoma of the jaw: a single institution experience. Med Oncol 2014 0.77
17 Targeted therapies: cui prodest? J Clin Oncol 2007 0.75
18 Water reuse: >90% water yield in MBR/RO through concentrate recycling and CO2 addition as scaling control. Water Res 2011 0.75
19 Anti-epidermal growth factor receptor skin toxicity: a matter of topical hydration. Anticancer Drugs 2016 0.75
20 Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy. Anticancer Drugs 2008 0.75